Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection
Biofilms
Assessment of Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection
1 other identifier
observational
35
1 country
1
Brief Summary
Prosthetic joint infection (PJI) represents one of the most common reasons for failure among hip and knee prostheses, with an incidence of around 1-2%. Infection can occur early (within days of surgery) or late (over a year after surgery), and no specific early markers for infection onset exist. Given the significant costs to the NHS for corrective revision surgery, the added suffering and risk to patients from surgery, and the risk of enhancing antimicrobial resistance through the use of broad-spectrum antibiotics, a more specific predictive test for early onset of infection is required.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 19, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 19, 2021
CompletedFirst Posted
Study publicly available on registry
April 7, 2023
CompletedApril 7, 2023
April 1, 2023
1.6 years
August 16, 2019
April 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Characteristic Formation of bacterial biofilm on orthopaedic implants
measured by infection assessment- this is the term for the measure
1 day study visit
Study Arms (1)
Orthopaedic Patients
Patients due to undergo prosthetic hip revision surgery
Interventions
Patients due to undergo prosthetic revision surgery for any reason (infection or aseptic)
Eligibility Criteria
Patients presenting with symptoms likely to require revision hip surgery for correction.
You may qualify if:
- Male or Female, aged 18 years or above.
- Due to undergo prosthetic revision surgery for any reason identified by the clinical team Willing to provide informed consent
You may not qualify if:
- Participant lacking capacity to give informed consent
- Any other clinical reason the participant should not be included in the study- at the discretion of the clinical team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Portsmouth Hospitals NHS Trustlead
- University of Portsmouthcollaborator
Study Sites (1)
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Portsmouth, Hampshire, PO6 3LY, United Kingdom
Biospecimen
Synovial Fluid
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2019
First Posted
April 7, 2023
Study Start
July 1, 2019
Primary Completion
January 19, 2021
Study Completion
January 19, 2021
Last Updated
April 7, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share